Patent Strategy in Pharmaceutical Industry: Are additional patents valuable?
This book investigates lifecycle management strategies used by pharmaceutical companies attempting to maximize the value of their product portfolio. Such strategies are sometimes referred to by generic drug companies as "evergreening". The analysis focuses on two of these strategies, namel...
Αποθηκεύτηκε σε:
Κύριος συγγραφέας: | Donghi, Monica (auth) |
---|---|
Μορφή: | Ηλεκτρονική πηγή Κεφάλαιο βιβλίου |
Γλώσσα: | Αγγλικά |
Έκδοση: |
Nomos Verlagsgesellschaft mbH & Co. KG
2014
|
Σειρά: | Munich Intellectual Property Law Center - MIPLC
|
Θέματα: | |
Διαθέσιμο Online: | DOAB: download the publication DOAB: description of the publication |
Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Second Generation Patents in Pharmaceutical Innovation
από: Ahn, Hyewon
Έκδοση: (2014) -
Patenting Proteomics Patentability and Scope of Protection of Three-Dimensional Protein Structure Claims under German, European and US law
από: Schuster, Martina
Έκδοση: (2010) -
Patentability Requirements for Nanotechnological Inventions An Approach from the European Patent Convention Perspective
από: Cisneros, Mario
Έκδοση: (2009) -
Patents in the Food Sector A Retrospective with Special Emphasis on the TRIPs Agreement
από: Willnegger, Eva
Έκδοση: (2008) -
Patents and Public Health Legalising the Policy Thoughts in the Doha TRIPS Declaration of 14 November 2001
από: Law, Andrew
Έκδοση: (2009)